Reversal of age-associated thymic atrophy: Treatments, delivery, and side effects

Richard Aspinall, Wayne Mitchell

Research output: Contribution to journalShort survey

35 Citations (Scopus)

Abstract

Our ability to survive infectious agents depends on making adequate immune responses, but as we get older our thymus atrophies. Production and export of T cells bearing new antigen receptor specificities to the peripheral T cell pool declines and results in shrinkage of the repertoire. Other changes in the peripheral T cell pool include an increase in cells moving closer to their replicative limit. Age related immune dysfunction, evident through the increased susceptibility to infection, follows these changes. Improvement in immune function in the elderly may require us to rejuvenate the immune system starting first with reversing the atrophy seen in the thymus. This has been achieved experimentally with interleukin 7, growth hormone, growth hormone secretagogues, keratinocyte growth factor or through chemical or surgical castration. The widespread use of one or more of these treatments will depend upon their effectiveness, their ease of delivery and the extent of any side effects.

Original languageEnglish
Pages (from-to)700-705
Number of pages6
JournalExperimental Gerontology
Volume43
Issue number7
Early online date1 May 2008
DOIs
Publication statusPublished - Jul 2008
Externally publishedYes

Fingerprint

T-cells
Atrophy
Thymus
T-Lymphocytes
Thymus Gland
Growth Hormone
Bearings (structural)
Fibroblast Growth Factor 7
Interleukin-7
Antigen Receptors
Immune system
Castration
Immune System
Therapeutics
Infection

Keywords

  • Interleukin-7
  • Keratinocyte growth factor
  • Sex steroid intervention
  • Thymic atrophy

ASJC Scopus subject areas

  • Biochemistry
  • Ageing
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology

Cite this

Reversal of age-associated thymic atrophy : Treatments, delivery, and side effects. / Aspinall, Richard; Mitchell, Wayne.

In: Experimental Gerontology, Vol. 43, No. 7, 07.2008, p. 700-705.

Research output: Contribution to journalShort survey

@article{8d577eda93c14aa485a4e346456b7557,
title = "Reversal of age-associated thymic atrophy: Treatments, delivery, and side effects",
abstract = "Our ability to survive infectious agents depends on making adequate immune responses, but as we get older our thymus atrophies. Production and export of T cells bearing new antigen receptor specificities to the peripheral T cell pool declines and results in shrinkage of the repertoire. Other changes in the peripheral T cell pool include an increase in cells moving closer to their replicative limit. Age related immune dysfunction, evident through the increased susceptibility to infection, follows these changes. Improvement in immune function in the elderly may require us to rejuvenate the immune system starting first with reversing the atrophy seen in the thymus. This has been achieved experimentally with interleukin 7, growth hormone, growth hormone secretagogues, keratinocyte growth factor or through chemical or surgical castration. The widespread use of one or more of these treatments will depend upon their effectiveness, their ease of delivery and the extent of any side effects.",
keywords = "Interleukin-7, Keratinocyte growth factor, Sex steroid intervention, Thymic atrophy",
author = "Richard Aspinall and Wayne Mitchell",
year = "2008",
month = "7",
doi = "10.1016/j.exger.2008.04.014",
language = "English",
volume = "43",
pages = "700--705",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Reversal of age-associated thymic atrophy

T2 - Treatments, delivery, and side effects

AU - Aspinall, Richard

AU - Mitchell, Wayne

PY - 2008/7

Y1 - 2008/7

N2 - Our ability to survive infectious agents depends on making adequate immune responses, but as we get older our thymus atrophies. Production and export of T cells bearing new antigen receptor specificities to the peripheral T cell pool declines and results in shrinkage of the repertoire. Other changes in the peripheral T cell pool include an increase in cells moving closer to their replicative limit. Age related immune dysfunction, evident through the increased susceptibility to infection, follows these changes. Improvement in immune function in the elderly may require us to rejuvenate the immune system starting first with reversing the atrophy seen in the thymus. This has been achieved experimentally with interleukin 7, growth hormone, growth hormone secretagogues, keratinocyte growth factor or through chemical or surgical castration. The widespread use of one or more of these treatments will depend upon their effectiveness, their ease of delivery and the extent of any side effects.

AB - Our ability to survive infectious agents depends on making adequate immune responses, but as we get older our thymus atrophies. Production and export of T cells bearing new antigen receptor specificities to the peripheral T cell pool declines and results in shrinkage of the repertoire. Other changes in the peripheral T cell pool include an increase in cells moving closer to their replicative limit. Age related immune dysfunction, evident through the increased susceptibility to infection, follows these changes. Improvement in immune function in the elderly may require us to rejuvenate the immune system starting first with reversing the atrophy seen in the thymus. This has been achieved experimentally with interleukin 7, growth hormone, growth hormone secretagogues, keratinocyte growth factor or through chemical or surgical castration. The widespread use of one or more of these treatments will depend upon their effectiveness, their ease of delivery and the extent of any side effects.

KW - Interleukin-7

KW - Keratinocyte growth factor

KW - Sex steroid intervention

KW - Thymic atrophy

UR - http://www.scopus.com/inward/record.url?scp=46949110881&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2008.04.014

DO - 10.1016/j.exger.2008.04.014

M3 - Short survey

VL - 43

SP - 700

EP - 705

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 7

ER -